Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells

SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Vaccination, supported by social and public health measures, has proven efficacious for reducing disease severity and virus spread. However, the emergence of highly transmissible viral variants that escape prior immunity highlights the need...

Full description

Bibliographic Details
Main Authors: Leo Yi Yang Lee, Randy Suryadinata, Conor McCafferty, Vera Ignjatovic, Damian F. J. Purcell, Phil Robinson, Craig J. Morton, Michael W. Parker, Gary P. Anderson, Paul Monagle, Kanta Subbarao, Jessica A. Neil
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Viruses
Subjects:
SARS-CoV-2
heparin
antiviral
nasal epithelial cells
Online Access:https://www.mdpi.com/1999-4915/14/12/2620

Internet

https://www.mdpi.com/1999-4915/14/12/2620

Similar Items